ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 222, Issue -, Pages 1476-1486
Publisher
Elsevier BV
Online
2022-10-01
DOI
10.1016/j.ijbiomac.2022.09.247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease
- (2022) Feng Zeng et al. JOURNAL OF NANOBIOTECHNOLOGY
- Genistein-Derived ROS-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis
- (2021) Wentao Fan et al. ACS Applied Materials & Interfaces
- Nanoencapsulation for Probiotic Delivery
- (2021) Franco Centurion et al. ACS Nano
- P071 Studying the effects of the probiotic bifidobacteria on gut health and intestinal epithelial cells function
- (2020) M Poletti et al. Journal of Crohns & Colitis
- Encapsulation of Lactobacillus rhamnosus in Hyaluronic Acid-Based Hydrogel for Pathogen-Targeted Delivery to Ameliorate Enteritis
- (2020) Yao Xiao et al. ACS Applied Materials & Interfaces
- Polymeric carriers for enhanced delivery of probiotics
- (2020) Shadi Asgari et al. ADVANCED DRUG DELIVERY REVIEWS
- Potential of lactic acid bacteria derived polysaccharides for the delivery and controlled release of oral probiotics
- (2020) Ning Liao et al. JOURNAL OF CONTROLLED RELEASE
- The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
- (2020) Dominika Jakubczyk et al. Nutrients
- Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
- (2019) Jason Lloyd-Price et al. NATURE
- Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis
- (2019) Shuangquan Gou et al. BIOMATERIALS
- Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
- (2019) Yonghyun Lee et al. NATURE MATERIALS
- Pathogen-targeting glycovesicles as a therapy for salmonellosis
- (2019) Haibo Mu et al. Nature Communications
- The potential of hyaluronic acid in immunoprotection and immunomodulation: Chemistry, processing and function
- (2018) Fernanda Zamboni et al. PROGRESS IN MATERIALS SCIENCE
- In situ self-spray coating system that can uniformly disperse a poorly water-soluble H2S donor on the colorectal surface to treat inflammatory bowel diseases
- (2018) Wei-Chih Lin et al. BIOMATERIALS
- Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
- (2018) Wei Li et al. BIOMATERIALS
- Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice
- (2017) Jürgen Stein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
- (2017) Sufeng Zhang et al. Nano Today
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promotion of In Vitro Chondrogenesis of Mesenchymal Stem Cells Using In Situ Hyaluronic Hydrogel Functionalized with Rod-Like Viral Nanoparticles
- (2016) Panita Maturavongsadit et al. BIOMACROMOLECULES
- Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa
- (2016) Seyed Yaser Vafaei et al. CARBOHYDRATE POLYMERS
- Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system
- (2016) Ran Li et al. JOURNAL OF CONTROLLED RELEASE
- Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model
- (2016) Éricka L. Souza et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice
- (2016) Hui-Lu Zhang et al. Experimental and Therapeutic Medicine
- Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria
- (2016) Haibo Mu et al. Scientific Reports
- Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans
- (2015) Grace B. Hatton et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease
- (2015) F.C.P. Tiago et al. Beneficial Microbes
- Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
- (2014) Asima Bhattacharyya et al. PHYSIOLOGICAL REVIEWS
- Regulation of intestinal homeostasis and immunity with probiotic lactobacilli
- (2013) Peter van Baarlen et al. TRENDS IN IMMUNOLOGY
- Oxidative stress in ulcerative colitis: an old concept but a new concern
- (2012) Gopabandhu Jena et al. FREE RADICAL RESEARCH
- Defensins and inflammation: The role of defensins in inflammatory bowel disease
- (2009) Malith Ramasundara et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa
- (2009) Boaz Tirosh et al. MOLECULAR PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started